Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug

Eduardo Vilar-Gomez, Naga Chalasani

Research output: Contribution to journalEditorial

Original languageEnglish (US)
JournalClinical Gastroenterology and Hepatology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Aspirin
Fibrosis
Pharmaceutical Preparations
Non-alcoholic Fatty Liver Disease

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

@article{40cf9b316ef14a3a9ff56c6076167267,
title = "Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug",
author = "Eduardo Vilar-Gomez and Naga Chalasani",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.cgh.2019.06.032",
language = "English (US)",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug

AU - Vilar-Gomez, Eduardo

AU - Chalasani, Naga

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85072760596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072760596&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2019.06.032

DO - 10.1016/j.cgh.2019.06.032

M3 - Editorial

C2 - 31252189

AN - SCOPUS:85072760596

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

ER -